Feeds › H-1B visa applications
H-1B visa applications
Labor condition applications that employers file with the US Department of Labor, a required step before an H-1B petition. An application is not a hire, and one can cover several workers.
About this data
- What it is
- Before an employer can petition the immigration service for a foreign worker in an H-1B job, it must file a labor condition application with the Department of Labor. The Department publishes every application it has decided, with the employer, job title, wage offered, prevailing wage, worksite and the number of workers asked for. This page ranks the employers that filed the most certified applications and lists the latest decisions. Applications for H-1B1 (Chile, Singapore) and E-3 (Australia) workers are in the same files.
- Who files it
- The employer files each application with the Department of Labor, Office of Foreign Labor Certification. The Department publishes the decided ones.
- How current
- The Department publishes the fiscal year to date about six weeks after each quarter ends (October to December is quarter one), so the newest decisions are about two months old. We check every week; most weeks nothing is new.
- Terms
- labor condition applicationA labor condition application (LCA) is the form an employer files with the Department of Labor before it petitions for an H-1B worker. The employer promises to pay at least the prevailing wage and to meet working-conditions rules. The Department certifies or denies it.not a hireAn application is not a hire, a petition or a visa. It is a step before a petition to the immigration service, which decides separately. The worker may never be hired, and one application can name many workers.decisionCertified: the Department certified the application. Certified, then withdrawn: it was certified and the employer withdrew it later. Denied: the Department denied it. Withdrawn: the employer withdrew it before a decision.wage offeredThe wage the employer offered, as filed, with its unit. The yearly figure restates it per year (hourly x 2,080, weekly x 52, every two weeks x 26, monthly x 12) from the low end of the offered range. It is not what the worker was paid.prevailing wageThe wage the Department treats as normal for the job and place. The employer must offer at least this much. It comes from the employer's own filing.company matchWe match the employer's name to a public company automatically, including a reviewed list of subsidiaries. A subsidiary can be missed and a similar name can be matched wrongly.
- Worth knowing
- An application is not a hire, a petition or a visa, and a certified application may never be used. One application can cover several workers, and staffing and consulting firms file many for work at other companies. A worksite or wage is as filed. Most employers are private companies, universities or staffing firms; we match a name to a public company automatically, so a subsidiary can be missed and a similar name matched wrongly.
All of this comes from the US Department of Labor, Office of Foreign Labor Certification, which publishes the decided applications. We are not affiliated with it.
Source and freshness · Information, not investment advice (disclaimer).
Applications decided per month, last 12 months of data
Certified Certified then withdrawn, denied or withdrawn
By the Department of Labor's decision date. Counts applications, not workers: one application can cover several. The newest months are about two months old and fill in each quarter. October 2025 is low: the federal government shutdown (Oct 1 to Nov 12) paused decisions.
Latest decided applications
Showing: ticker NTLA
| Decided | EmployerWe match the employer's name to a public company automatically, including a reviewed list of subsidiaries. A subsidiary can be missed and a similar name can be matched wrongly. | Job title | WorkersThe number of workers the application asks for. One application can name many; the count is a request, not a count of people who started work. | Wage offeredThe wage the employer offered, as filed, with its unit. The yearly figure restates it per year (hourly x 2,080, weekly x 52, every two weeks x 26, monthly x 12) from the low end of the offered range. It is not what the worker was paid. | Worksite | DecisionCertified: the Department certified the application. Certified, then withdrawn: it was certified and the employer withdrew it later. Denied: the Department denied it. Withdrawn: the employer withdrew it before a decision. | CaseEvery application has a Department of Labor case number. Copy it, then paste it into the Department's case status search to see that application's status and dates on the government site. The full record, with the wage and job title, is in the Department's quarterly disclosure files. |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | NTLA Intellia Therapeutics, Inc. | Senior Computational Scientist Bioinformatics Scientists | 1 | $176,675 | Cambridge, MA | Certified | I-200-26150-964966 |
| Apr 16, 2026 | NTLA Intellia Therapeutics, Inc. | Scientist Bioinformatics Scientists | 1 | $143,800 | Cambridge, MA | Certified | I-200-26099-774430 |
| Apr 8, 2026 | NTLA Intellia Therapeutics, Inc. | Scientist Molecular and Cellular Biologists | 1 | $147,400 | Cambridge, MA | Certified | I-200-26092-749789 |
| Jan 29, 2026 | NTLA Intellia Therapeutics, Inc. | Senior Associate Scientist Bioinformatics Scientists | 1 | $129,000 | Cambridge, MA | Certified | I-200-26022-581597 |
| Jan 29, 2026 | NTLA Intellia Therapeutics, Inc. | Associate Scientist Bioinformatics Scientists | 1 | $117,000 | Cambridge, MA | Certified | I-200-26022-580832 |
| Jan 29, 2026 | NTLA Intellia Therapeutics, Inc. | Senior Associate Scientist Bioinformatics Scientists | 1 | $123,500 | Cambridge, MA | Certified | I-200-26022-580744 |
| Jan 29, 2026 | NTLA Intellia Therapeutics, Inc. | Senior Associate Scientist Molecular and Cellular Biologists | 1 | $131,700 | Cambridge, MA | Certified | I-200-26022-580716 |
| Dec 1, 2025 | NTLA Intellia Therapeutics, Inc. | Senior Software Engineer II Data Scientists | 1 | $177,900 | Cambridge, MA | Certified | I-200-25325-427993 |
| Jun 6, 2025 | NTLA Intellia Therapeutics, Inc. | Senior Associate Scientist Bioinformatics Scientists | 1 | $132,400 | Cambridge, MA | Certified | I-200-25150-033483 |
| May 13, 2025 | NTLA Intellia Therapeutics, Inc. | Senior Manager, Regulatory Affairs Regulatory Affairs Managers | 1 | $182,900 | Cambridge, MA | Certified | I-200-25126-942521 |
| Apr 10, 2025 | NTLA Intellia Therapeutics, Inc. | Scientist Bioinformatics Scientists | 1 | $135,000 | Cambridge, MA | Certified | I-200-25093-828934 |
| Mar 31, 2025 | NTLA Intellia Therapeutics, Inc. | Director, Global Regulatory Strategy Regulatory Affairs Specialists | 1 | $245,000 | Cambridge, MA | Certified | I-200-25083-797629 |
| Mar 10, 2025 | NTLA Intellia Therapeutics, Inc. | Associate Scientist Bioinformatics Scientists | 1 | $112,400 | Cambridge, MA | Certified | I-200-25062-738016 |
| Mar 10, 2025 | NTLA Intellia Therapeutics, Inc. | Process Development Engineer II Molecular and Cellular Biologists | 1 | $121,300 | Cambridge, MA | Certified | I-200-25062-737495 |
| Feb 28, 2025 | NTLA Intellia Therapeutics, Inc. | Principal Scientist Bioinformatics Scientists | 1 | $172,100 | Cambridge, MA | Certified | I-200-25052-713825 |
| Feb 28, 2025 | NTLA Intellia Therapeutics, Inc. | Senior Computational Scientist Bioinformatics Scientists | 1 | $165,000 | Cambridge, MA | Certified | I-200-25052-713796 |
| Feb 21, 2025 | NTLA Intellia Therapeutics, Inc. | Senior Scientist, Preclinical Development Bioinformatics Scientists | 1 | $142,400 | Cambridge, MA | Certified | I-200-25044-690122 |
| Feb 10, 2025 | NTLA Intellia Therapeutics, Inc. | Associate Director, Access & HEOR Strategy Bioinformatics Scientists | 1 | $211,700 | Cambridge, MA | Certified | I-200-25034-661182 |
| Feb 4, 2025 | NTLA Intellia Therapeutics, Inc. | Scientist Protein Engineering Bioinformatics Scientists | 1 | $140,200 | Cambridge, MA | Certified | I-200-25028-646720 |
| Oct 17, 2024 | NTLA Intellia Therapeutics, Inc. | Senior Specialist, CMC Operations Regulatory Affairs Managers | 1 | $113,500 | Cambridge, MA | Certified | I-200-24283-394760 |
| Oct 8, 2024 | NTLA Intellia Therapeutics, Inc. | Senior Scientist Bioinformatics Scientists | 1 | $156,000 | Cambridge, MA | Certified | I-200-24275-377092 |
| Sep 24, 2024 | NTLA Intellia Therapeutics, Inc. | Associate Director, Quality Control Bioinformatics Scientists | 1 | $183,500 | Cambridge, MA | Certified | I-200-24261-343024 |
| Sep 16, 2024 | NTLA Intellia Therapeutics, Inc. | Software Engineer II Software Developers | 1 | $120,500 | Cambridge, MA | Certified | I-200-24253-322843 |
| Sep 3, 2024 | NTLA Intellia Therapeutics, Inc. | Associate Scientist Molecular and Cellular Biologists | 1 | $112,000 | Cambridge, MA | Certified | I-200-24239-292791 |
| Aug 9, 2024 | NTLA Intellia Therapeutics, Inc. | Senior Research Associate Bioinformatics Scientists | 1 | $98,800 | Cambridge, MA | Certified | I-200-24215-240734 |
| Aug 7, 2024 | NTLA Intellia Therapeutics, Inc. | Senior Associate Scientist Bioinformatics Scientists | 1 | $127,900 | Cambridge, MA | Certified | I-200-24213-234262 |
| Jul 5, 2024 | NTLA Intellia Therapeutics, Inc. | Quality Control Lead Quality Control Systems Managers | 1 | $126,400 | Cambridge, MA | Certified | I-200-24179-155524 |
| Jul 5, 2024 | NTLA Intellia Therapeutics, Inc. | Principal Scientist, Analytical Development Bioinformatics Scientists | 1 | $161,700 | Cambridge, MA | Certified | I-200-24179-155371 |
| May 9, 2024 | NTLA Intellia Therapeutics, Inc. | Scientist Biochemists and Biophysicists | 1 | $133,400 | Cambridge, MA | Certified | I-200-24123-949251 |
| May 7, 2024 | NTLA Intellia Therapeutics, Inc. | Senior Associate Scientist Bioinformatics Scientists | 1 | $127,900 | Cambridge, MA | Certified | I-200-24121-939973 |
| Apr 16, 2024 | NTLA Intellia Therapeutics, Inc. | Associate Scientist Molecular and Cellular Biologists | 1 | $111,150 | Cambridge, MA | Certified | I-200-24100-868722 |
| Apr 9, 2024 | NTLA Intellia Therapeutics, Inc. | Senior Scientist Biochemists and Biophysicists | 1 | $150,800 | Cambridge, MA | Certified | I-200-24093-848170 |
| Mar 26, 2024 | NTLA Intellia Therapeutics, Inc. | Senior Associate Scientist Bioinformatics Scientists | 1 | $118,800 | Cambridge, MA | Certified | I-200-24079-811133 |
| Mar 21, 2024 | NTLA Intellia Therapeutics, Inc. | Scientist Biochemists and Biophysicists | 1 | $137,800 | Cambridge, MA | Certified | I-200-24074-800620 |
| Mar 21, 2024 | NTLA Intellia Therapeutics, Inc. | Senior Associate Scientist Bioinformatics Scientists | 1 | $127,900 | Cambridge, MA | Certified | I-200-24074-799012 |
| Mar 19, 2024 | NTLA Intellia Therapeutics, Inc. | Research Associate Bioinformatics Scientists | 1 | $83,200 | Cambridge, MA | Certified | I-200-24072-792127 |
| Mar 19, 2024 | NTLA Intellia Therapeutics, Inc. | Senior Associate Scientist Bioinformatics Scientists | 1 | $124,900 | Cambridge, MA | Certified | I-200-24072-792126 |
| Mar 19, 2024 | NTLA Intellia Therapeutics, Inc. | Principal Scientist Bioinformatics Scientists | 1 | $172,100 | Cambridge, MA | Certified | I-200-24072-792125 |
| Mar 19, 2024 | NTLA Intellia Therapeutics, Inc. | Scientist, Screening Methods and Process Develo… Bioinformatics Scientists | 1 | $143,600 | Cambridge, MA | Certified | I-200-24072-792123 |
| Mar 19, 2024 | NTLA Intellia Therapeutics, Inc. | Software Engineer I Software Developers | 1 | $112,300 | Cambridge, MA | Certified | I-200-24072-792118 |
| Mar 19, 2024 | NTLA Intellia Therapeutics, Inc. | Lead Quality Control Quality Control Systems Managers | 1 | $124,000 | Cambridge, MA | Certified | I-200-24072-792117 |
| Mar 19, 2024 | NTLA Intellia Therapeutics, Inc. | Scientist, Oligonucleotide & Small Molecule Pro… Molecular and Cellular Biologists | 1 | $140,000 | Cambridge, MA | Certified | I-200-24072-792115 |
| Mar 19, 2024 | NTLA Intellia Therapeutics, Inc. | Senior Scientist, AAV Vector Biology Molecular and Cellular Biologists | 1 | $146,700 | Cambridge, MA | Certified | I-200-24072-792114 |
| Mar 19, 2024 | NTLA Intellia Therapeutics, Inc. | Scientist, PreClinical in vitro Pharmacology Molecular and Cellular Biologists | 1 | $133,200 | Cambridge, MA | Certified | I-200-24072-792111 |
| Mar 19, 2024 | NTLA Intellia Therapeutics, Inc. | Senior Research Associate Molecular and Cellular Biologists | 1 | $96,700 | Cambridge, MA | Certified | I-200-24072-792110 |
| Mar 19, 2024 | NTLA Intellia Therapeutics, Inc. | Director, Clinical Operations Clinical Data Managers | 1 | $223,300 | Cambridge, MA | Certified | I-200-24072-792109 |
| Mar 19, 2024 | NTLA Intellia Therapeutics, Inc. | Associate Scientist, AAV Process Development Bioinformatics Scientists | 1 | $114,400 | Cambridge, MA | Certified | I-200-24072-792104 |
| Mar 19, 2024 | NTLA Intellia Therapeutics, Inc. | Scientist Microbiologists | 1 | $140,200 | Cambridge, MA | Certified | I-200-24072-792103 |
| Mar 19, 2024 | NTLA Intellia Therapeutics, Inc. | Associate Director, Nonclinical Scientific Writ… Technical Writers | 1 | $187,400 | Cambridge, MA | Certified | I-200-24072-792102 |
| Mar 19, 2024 | NTLA Intellia Therapeutics, Inc. | Computational Scientist Bioinformatics Scientists | 1 | $142,500 | Cambridge, MA | Certified | I-200-24072-792100 |
The newest 50 items, most recent first. Each row links to the Department of Labor's disclosure data page; its files carry no worker names. Updated Nov 15, 2026, 4:50 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances